Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$4.37M
298.77K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 298.77K shares of JANUX THERAPEUTICS, INC. valued at approximately $4.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/13/2026ACC: 0001950047-26-003390
Officer· Chief Business Officer
Since Jun 2021
298.77K
Shares to sell
$4.37M
Approx. market value
1.88K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of options under a registered plan
Cash
4/13/2026
1.88KExercise of options under a registered plan
Cash
4/13/2026
1.00Total acquired1.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Exercise of options under a registered plan Cash | 1.88K | — |
4/13/2026 | Exercise of options under a registered plan Cash | 1.00 | — |
| Total | 1.88K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
178.77K
Market value
$2.60M
1/26/2026
—Completed
Units to sell
118.12K
Market value
$1.74M
1/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.88K
Market value
$28.2K
4/13/2026
Total
Units
298.77K
Value
$4.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 178.77K | $2.60M | — | Completed |
1/23/2026 | 118.12K | $1.74M | — | Completed |
| Planned — Approximate Date | ||||
4/13/2026 | 1.88K | $28.2K | NASDAQ | Planned |
| Total | 298.77K | $4.37M | ||